Genes2Me, a leading IVD manufacturer and genetic diagnostics company, recently launched its brand new product RT- Direct Multiplex RT PCR kit for Covid-19. Validated at ICMR approved centre with 100% ...

Genes2Me announced on Monday that it has recently launched a real-time PCR kit, which detects Influenza A/B, RSV and SARS-CoV-2. With the help of this kit, COVFlu, influenza A/B, RSV, RNaseP, and ...

this kit is available as Research-Use only (RUO) and based on Gold standard Taqman chemistry-based RT PCR method, the company claims. Genes2Me Pvt. Ltd. on Tuesday announced that they have developed ...

New Delhi, May 10 (PTI) Drug major Cipla on Tuesday said it has launched a COVID-19 RT PCR testing kit in the country in partnership with diagnostics firm Genes2Me. New Delhi, May 10 (PTI) Drug major ...

Genetic Diagnostics Company Genes2Me, on Monday launched RT- Direct Multiplex RT-PCR kit for COVID-19 that displays results in 40 minutes without any RNA extraction kit and instrument. The Made in ...

Genes2Me, a leading Genetic diagnostics and research Company, launched its high throughput RT PCR testing lab for COVID-19 and other Infectious diseases at Gurgaon with a current capacity of testing ...

New Delhi: With a production capacity of 9 million tests in a week, Indian manufacturer Genes2me has become one of the largest manufacturers of COVID-19 testing kits in the country. The company has ...

With the launch of the "RT-Direct multiplex COVID-19 RT PCR" test kit, the Mumbai-based drug firm is expanding its diagnostics offerings, it said in a regulatory filing. Drug major Cipla on Tuesday ...